June 1, 2023Evolving landscape of HER2-low breast cancer: New diagnosis and treatment paradigm shiftIn the US, breast cancer is the most common cancer and the second most common cause of cancer death among women.1 Like other cancers, breast cancer is a heterogeneous disease with various oncogenic drivers. Read more »
January 19, 2019Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing Read more »
